Billings Clinic
Especially For:

Clinical Trials

Title   GU 90802 Renal Cell Carcinoma Advanced
Description   CTSU C90802 Randomized Phase III Trial Comparing Everolimus Plus Placebo vs Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors
IRB Number   CTSU 90802
Category   Genitourinary
Status   Active
Start Date   11/10/2010
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller, RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-0782
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.